V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310002736 | 310001163 | 1.78 | 124.9 | Palliative (P) | 2016-04-18 | 2016-05-09 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310015971 | CISPLATIN + GEMCITABINE |
| 310002737 | 310001164 | null | 99.5 | Curative (C) | 2014-03-08 | 2014-03-12 | Retinoblastoma JOE | N | N | 310015973 | CEV |
| 310002738 | 310001164 | 1.55 | 78.9 | Palliative (P) | 2015-08-21 | 2015-09-12 | DOXORUBICIN | N | N | 310015973 | DOXORUBICIN |
| 310002739 | 310001164 | 1.59 | 77 | Adjuvant (A) | 2014-10-29 | 2014-11-11 | Cisplatin 7 day | null | Y | 310015973 | CISPLATIN |
| 310002740 | 310001165 | 1.63 | 60.6 | Palliative (P) | 2014-10-23 | 2014-10-23 | Carboplatin + Etoposide IV 3 day | 02 | N | 310015985 | CARBOPLATIN + ETOPOSIDE |
| 310002741 | 310001166 | 1.75 | 53.9 | null | 2014-11-18 | 2014-11-29 | CHOP R - 21 days | 02 | N | 310015987 | CHOP R |
| 310002742 | 310001167 | 1.8 | null | Curative (C) | 2014-10-22 | 2014-11-05 | Cisplatin | N | N | 310015989 | CISPLATIN |
| 310002743 | 310006441 | 1.63 | 56.4 | null | 2016-06-29 | 2016-07-13 | CHOP R - 21 days | 2 | N | 310015990 | CHOP R |
| 310002744 | 310006441 | 1.74 | 74.6 | Adjuvant (A) | 2016-07-08 | 2016-07-09 | Cisplatin | 02 | Y | 310015990 | CISPLATIN |
| 310002745 | 310001168 | null | 75.6 | Curative (C) | 2014-11-25 | 2014-11-27 | Retinoblastoma JOE | N | N | 310015994 | CEV |
| 310002746 | 310001168 | 1.79 | 72.8 | Adjuvant (A) | 2017-07-11 | 2017-10-25 | Trial Unspecified | 01 | N | 310015994 | TRIAL |
| 310002747 | 310001169 | 1.71 | 81.7 | Palliative (P) | null | 2015-05-29 | Carboplatin + Etoposide iv&po | null | Y | 310015999 | CARBOPLATIN + ETOPOSIDE |
| 310002749 | 310001171 | 1.53 | 84.3 | Palliative (P) | 2014-06-22 | 2014-07-03 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016015 | CISPLATIN + GEMCITABINE |
| 310002750 | 310001172 | null | 80.6 | Palliative (P) | 2016-02-14 | 2016-02-15 | Ipilimumab | N | N | 310016018 | IPILIMUMAB |
| 310002751 | 310001172 | null | 12.1 | Curative (C) | 2016-07-31 | 2016-08-01 | Retinoblastoma JOE | 2 | N | 310016018 | CEV |
| 310002752 | 310008945 | 1.77 | 85.21 | Palliative (P) | 2016-09-14 | 2016-09-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016025 | CISPLATIN + GEMCITABINE |
| 310002753 | 310008945 | 1.53 | 86 | Palliative (P) | 2017-04-25 | 2017-05-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016025 | CISPLATIN + GEMCITABINE |
| 310002754 | 310001173 | 1.78 | 83 | Curative (C) | 2014-08-25 | 2014-08-26 | PEMBROLIZUMAB | N | N | 310016034 | PEMBROLIZUMAB |
| 310002756 | 310001174 | 1.7 | 64.9 | Curative (C) | 2015-12-26 | 2015-12-27 | CHOP R - 21 days | N | N | 310016043 | CHOP R |
| 310002757 | 310001174 | 1.66 | 80.6 | Curative (C) | null | 2018-07-02 | Trial Unspecified | Y | N | 310016043 | TRIAL |
| 310002758 | 310001174 | 1.7 | 81 | Palliative (P) | 2014-12-20 | 2014-12-29 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310016043 | CISPLATIN + GEMCITABINE |
| 310002759 | 310001175 | null | null | Palliative (P) | 2018-01-22 | 2018-01-23 | PEMBROLIZUMAB | 02 | N | 310016049 | PEMBROLIZUMAB |
| 310002760 | 310001175 | null | 74.6 | Palliative (P) | 2017-02-07 | 2017-02-07 | Trial Unspecified | Y | N | 310016049 | TRIAL |
| 310002761 | 310001175 | null | null | Palliative (P) | 2017-10-24 | 2017-10-26 | PEMBROLIZUMAB | 02 | N | 310016049 | PEMBROLIZUMAB |
| 310002762 | 310001175 | 0 | 71.8 | Curative (C) | 2017-08-17 | 2017-09-06 | Retinoblastoma JOE | N | N | 310016049 | CEV |
| 310002763 | 310001175 | 1.77 | 88.55 | Palliative (P) | 2016-08-20 | 2016-08-28 | Carboplatin + Etoposide iv&po | N | N | 310016049 | CARBOPLATIN + ETOPOSIDE |
| 310002764 | 310001175 | 1.7 | 60.5 | Palliative (P) | 2014-04-23 | 2014-04-30 | CISPLATIN + GEMCITABINE | N | N | 310016049 | CISPLATIN + GEMCITABINE |
| 310002765 | 310001176 | null | 92.5 | Palliative (P) | 2014-10-20 | 2014-10-23 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016069 | CISPLATIN + GEMCITABINE |
| 310002766 | 310001177 | 0 | null | Curative (C) | 2017-08-17 | 2017-08-28 | Retinoblastoma JOE | N | N | 310016073 | CEV |
| 310002767 | 310001178 | 1.67 | 102.9 | Palliative (P) | 2017-06-17 | 2017-06-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016074 | CISPLATIN + GEMCITABINE |
| 310002768 | 310001178 | 1.77 | null | Palliative (P) | null | 2017-09-20 | Ipilimumab | 02 | null | 310016074 | IPILIMUMAB |
| 310002769 | 310001178 | null | null | Palliative (P) | 2017-06-23 | 2017-06-28 | Ipilimumab | 2 | N | 310016074 | IPILIMUMAB |
| 310002770 | 310001179 | 1.7 | null | Palliative (P) | 2016-09-02 | 2016-09-04 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016085 | CISPLATIN + GEMCITABINE |
| 310002771 | 310001180 | 1.7 | 84.3 | Palliative (P) | null | 2015-02-20 | CARBOPLATIN + ETOPOSIDE | N | N | 310016099 | CARBOPLATIN + ETOPOSIDE |
| 310002772 | 310001181 | 1.75 | 73.1 | Palliative (P) | 2017-08-22 | 2017-08-28 | DOXORUBICIN | 2 | null | 310016100 | DOXORUBICIN |
| 310002773 | 310001181 | null | 74.1 | null | 2016-05-30 | 2016-05-30 | Ipilimumab | N | N | 310016100 | IPILIMUMAB |
| 310002774 | 310001181 | 1.63 | 66.15 | Adjuvant (A) | 2016-11-06 | 2016-11-16 | CARBOPLATIN + ETOPOSIDE | N | Y | 310016100 | CARBOPLATIN + ETOPOSIDE |
| 310002775 | 310001181 | 1.82 | 100 | Palliative (P) | 2013-12-05 | 2013-12-08 | Ipilimumab | N | N | 310016100 | IPILIMUMAB |
| 310002776 | 310011009 | 1.87 | 64 | Palliative (P) | 2014-02-09 | 2014-02-18 | Doxorubicin 75mg/m2 | 2 | N | 310016116 | DOXORUBICIN |
| 310002777 | 310001182 | null | 48.8 | Palliative (P) | 2017-09-23 | 2017-10-09 | Trial Unspecified | Y | N | 310016118 | TRIAL |
| 310002778 | 310006449 | null | null | Curative (C) | 2015-12-11 | 2016-01-13 | Retinoblastoma JOE | N | N | 310016120 | CEV |
| 310002779 | 310006449 | 1.82 | 82 | Palliative (P) | 2016-04-17 | 2016-04-23 | Ipilimumab | 2 | N | 310016120 | IPILIMUMAB |
| 310002780 | 310006449 | 1.79 | 68.1 | Palliative (P) | 2013-03-05 | 2013-03-31 | Cisplatin + Gemcitabine (D 1 & 8) | N | 2 | 310016120 | CISPLATIN + GEMCITABINE |
| 310002781 | 310001183 | null | null | Not known (9) | 2017-10-28 | 2017-10-29 | PEMBROLIZUMAB | Y | N | 310016128 | PEMBROLIZUMAB |
| 310002782 | 310006450 | 1.7 | 88.5 | Palliative (P) | null | 2017-01-27 | PEMBROLIZUMAB | N | N | 310016129 | PEMBROLIZUMAB |
| 310002783 | 310001184 | null | 71.2 | Palliative (P) | 2015-10-09 | 2015-10-23 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016134 | CISPLATIN + GEMCITABINE |
| 310002784 | 310001184 | 1.8 | 76.1 | Curative (C) | 2017-07-13 | 2017-07-31 | Cisplatin | N | Y | 310016134 | CISPLATIN |
| 310002785 | 310001184 | 1.6 | 76 | Palliative (P) | 2015-07-19 | 2015-08-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016134 | CISPLATIN + GEMCITABINE |
| 310002786 | 310010274 | null | 110.5 | Curative (C) | null | 2014-04-09 | Selumetinib | 01 | N | 310016142 | TRIAL |
| 310002787 | 310001185 | 1.83 | 85.2 | Curative (C) | 2017-07-24 | 2017-08-24 | CHOP R - 21 days | null | N | 310016143 | CHOP R |